Four- to twenty-four-hour uptake ratio: An index of rapid iodine-131 turnover in hyperthyroidism

Journal of Nuclear Medicine

Volumn 37, Issue 11, 1996, Pages 1815-1819

  Aktay, Recai ^a   Rezai, Karim ^a,b   Seabold, James E ^a   Bar, Robert S ^a   Kirchner, Peter T ^a  

^a UNIVERSITY OF IOWA   (United States)

^b UNIVERSITY OF IOWA HOSPITALS AND CLINICS   (United States)

Author keywords

Graves' disease; hyperthyroidism; rapid thyroidal iodine 131 turnover

Indexed keywords

IODINE 131;

ADULT; ARTICLE; CLINICAL TRIAL; FEMALE; GENDER; GRAVES DISEASE; HUMAN; HYPERTHYROIDISM; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RADIOISOTOPE THERAPY; TREATMENT OUTCOME;

ADULT; FEMALE; HUMANS; HYPERTHYROIDISM; IODINE RADIOISOTOPES; MALE; REGRESSION ANALYSIS; THYROID GLAND; TIME FACTORS; TREATMENT FAILURE;

EID: 0029913548     PISSN: 01615505     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (36)

1. Solomon B, Glinoer D, LaGasse R, Wartofsky L. Current trends in the management of Graves' disease. J Clin Endocrinol Metab 1990;70:1518-1524.
2. 131I) treatment of hyperthyroidism. In: Freeman LM, Weissmann HS, eds. Nuclear medicine annual. New York: Raven Press; 1982;265-290.
3. Graham GD, Burman KD. Radioiodine treatment of Graves' disease: an assessment of its potential risks. Ann Intern Med 1986;105:900-905.
4. Shapiro B. Optimization of radioiodine therapy of thyrotoxicosis: what have we learned after 50 yr? J Nucl Med 1993;34:1638-1641.
5. Rapoport B, Caplan R, DeGroot LJ. Low-dose sodium iodide-131 therapy in Graves' disease. JAMA 1973;224:1610-1613.
6. 131I therapy of Graves' disease. Ann Intern Med 1977;87:441-443.
7. Goolden AWG, Stewart JSW. Long-term results from graded low dose radioactive iodine therapy for thyrotoxicosis. Clin Endocrinol 1986;24:217-222.
8. Nordyke RA, Gilbert FI Jr. Optimal iodine-131 dose for eliminating hyperthyroidism in Graves' disease. J Nucl Med 1991;32:411-416.
9. Harbert JC. Radioiodine therapy of hyperthyroidism. In: Harbert JC, Eckelman WC, Neumann RD, eds. Nuclear medicine diagnosis and therapy. New York: Thieme Medical Publishing Inc.; 19;951-973.
10. Berg GEB, Michanek AMK, Holmberg ECV, Fink M. Iodine-131 treatment of hyperthyroidisim: significance of effective half-life measuremments. J Nucl Med 1996;37:228-232.
11. Clerc J, Izembart M, Dagousset F, et al. Influence of dose selection on absorbed dose profiles in radioiodine treatment of diffuse toxic goiters in patients receiving or not receiving carbimazole. J Nucl Med 1993;34:387-393.
12. Malamos BK, Daikos GK, Samara V, Koutras DA. The use of radioiodine for the diagnosis and treatment of thyroid diseases. Acta Endocrinol (Copenh) 1959;32:311-329.
13. Jackson GL. Calculated low dose radio-iodine therapy of thyrotoxicosis. Int J Nucl Med Biol 1975;2:80-81.
14. 131I therapy of thyrotoxicosis. Calculations with reference to leukemia. Br Med J 1961;2:210-215.
15. McConahey WM, Keating FR Jr, Power MH. The behavior of radioiodine in the blood. Clin Invest 1949;28:191-198.
16. Rall JE, Sonenberg MS, Robbins J, Lazerson R, Rawson RW. The blood level as guide to therapy with radioiodine. J Clin Endocrinol Metab 1953;13:1369-1377.
17. Koutras DA, Alexander WD, Buchanan WW, Crooks J, Wayne EJ. Studies of stable iodine metabolism as a guide to the interpretation of radioiodine tests. Acta Endocrinol (Copenh) 1961;37:597-606.
18. Alevizaki CC, Alevizaki-Harhalaki MC, Ikkos DG. Radioiodine-131 treatment of thyrotoxicosis: dose required for and some factors affecting the early induction of hypothyroidism. Eur J Nucl Med 1985;10:450-454.
19. Cunnien AJ, Hay ID, Gorman CA, Offord KP, Scanlon PW. Radioiodine-induced hypothyroidism in Graves' disease: factors associated with the increasing incidence. J Nucl Med 1982;23:978-983.
20. Hoffman DA. Late effects of iodine-131 therapy in the United States. In: Boice JD Jr, Fraument JF Jr, eds. Radiation carcinogenesis. New York: Raven Press 1984;273-280.
21. 131I therapy for hyperthyroidism. Clin Endocrinol 1977;6:329-332.
22. Bliddal H, Hansen JM, Rogowski P, Johansen K, Friis T, Siersbaek-Nielsen K. Iodine-131 treatment of diffuse and nodular toxic goitre with or without antithyroid agents. Acta Endocrinol (Copenh) 1982;99:517-521.
23. Sridama V, McCormick M, Kaplan EL, Fauchet R, DeGroot LJ. Long-term follow-up study of compensated low-dose iodine-131 therapy for Graves' disease. N Engl J Med 1984;311:426-432.
24. Wu P, McIver B, Thomson K, Toft A. Predictive factors of recurrent hyperthyroidism following radioactive iodine treatment for Graves' disease [Abstract]. The Endocrine Society, Program and Abstracts 1994;41:264.
25. Steinbach JJ, Donoghue GD, Goldman JK. Simultaneous treatment of toxic diffuse goiter with iodine-131 and antithyroid drugs: a prospective study. J Nucl Med 1979;20:1263-1267.
26. Einhorn J, Saterborg NE. Antithyroid drugs in iodine-131 therapy of hyperthyroidism. Acta Radiology 1962;58:161-167.
27. Limperos G, Mosher WA. Protection of mice against x-radiation by thiourea. Science 1950;112:86-87.
28. Goolden AWG, Fraser TR. Effect of pretreatment with carbimazole in patients with thyrotoxicosis subsequently treated with radioactive iodine. Br Med J 1969;3:443-444.
29. Gimlette TMD, Kocak R, Herbert RG, Squire CR. The effect of carbimazole following radioiodine therapy on radiation dose to the thyroid. Nuklearmedizin 1981;20:72-75.
30. Heath RC, Gossain VV, Rovner DR. Alteration of radioactive iodine uptake after treatment of hyperthyroidism with iodine-131. South Med J 1988;81:601-605.
31. Goldsmith R. Experience with the radioiodine tracer test in radioiodine-treated thyrotoxic patients. Am J Med Sci 1954;227:403-407.
32. 131I. Clin Sci 1960;20:87-97.
33. DeGroot LJ, Mangklabruks A, McCormick M. Comparison of RAI iodine-131 treatment protocols for Graves' disease. J Endocrinol Invest 1990;13:111-118.
34. Becker DV, Hurley JR, Zanzonico PB, Kusic Z. Antithyroid drugs given during iodine-131 treatment maintain clinical control of hyperthyroidism and reduce whole body radiation [Abstract]. Endocrinology Suppl 1988;121:23.
35. Burrow GN, Burke WR, Himmelhoch JM, Spencer RP, Hershman JM. Effect of lithium on thyroid function. J Clin Endocrinol 1971;32:647-652.
36. Brunn J, Block U, Ruf G, Bos I, Kunze WP, Scriba PC. Volumetrie der Schilddrusenlappen mittels real-time-sonographie. Dtsch Med Wochenschr 1981;106:1338-1340.